Sat 28 Nov 2009 | 18:04 EST
You are here: Home > Business & Finance > Stocks > Overview > Company Profile
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Company Profile
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Full Description

North China Pharmaceutical Company. Ltd (600812.SS) (Shanghai Stock Exchange)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty · View 600812 on other exchanges
As of  27 Nov 2009
10.47CNY
Price Change
-0.13
Percent Change
-1.23%
 
Research Another Stock: Symbol Look-up

 
Back to the Company Overview
North China Pharmaceutical Company. Ltd is a China-based company primarily engaged in manufacture and sale of pharmaceuticals. The Company’s major products are classified as penicillin, semi-finished penicillin, cephalosporin and vitamin products. The Company also provides raw materials of pharmaceuticals, agricultural chemicals and veterinary drugs, health care products and pharmaceutical packaging materials, among others. It distributes its products in domestic and overseas markets.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.